Shifa Medical

“Barigen 4 mg (Baricitinib),” meticulously crafted by General Pharma Ltd. and distributed by Orio Pharma, marks a significant advancement in autoimmune care. This innovative medication, with Baricitinib as its active component, belongs to the class of Janus kinase (JAK) inhibitors, signifying a paradigm shift in treating autoimmune disorders with a focus on precision and efficacy.

It helps people who have COVID-19 to stay out of the hospital. It is not for use by people who are hospitalized due to COVID-19. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19.

Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate.

Ziverdo Kit is a combination medicine that is used to treat bacterial and parasitic infections in the body. It kills and stops the growth of bacteria and parasites and prevents the further spread of the infection. This way it helps in speedy healing and recovery of the symptoms caused by the infection.

Descriptions. Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate.

Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. It is used by adults 18 years of age and older who have had mild to moderate symptoms for no more than 5 days and are not hospitalized.